Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Go back to Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Bruker (BRKR) PT Lowered to $85 at Jefferies

February 14, 2022 7:53 AM EST

Jefferies analyst Brandon Couillard lowered the price target on Bruker (NASDAQ: BRKR) to $85.00 (from $95.00) while maintaining a Buy rating following a "solid" Q4 with good momentum heading into 2022.

The analyst commented, "BRKR's +6-8% core growth outlook is similar to other top Tools peers,... More

Bruker (BRKR) Tops Q4 EPS by 1c, Offers Guidance

February 11, 2022 7:04 AM EST

Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.59, $0.01 better than the analyst estimate of $0.58. Revenue for the quarter came in at $683.5 million versus the consensus estimate of $663.88 million.

GUIDANCE:

Bruker sees Q1 2022 EPS of $2.29-$2.33, versus the consensus of $2.29.

For FY 2022, Bruker... More